• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ImmunoGen Inc

+ Add to Watchlist

IMU:GR

9.496 EUR 0.669 7.58%

As of 03:59:15 ET on 04/16/2014.

Snapshot for ImmunoGen Inc (IMU)

Open: 9.311 Day's Range: 9.269 - 9.525 Volume: 500
Previous Close: 8.827 52wk Range: 8.827 - 15.515 1-Yr Rtn: -15.05%

Stock Chart for IMU

No chart data available.
  • IMU:GR 9.496
  • 1D
  • 1M
  • 1Y
8.827
Interactive IMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMU

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) -0.6800
Est. PEG Ratio -
Market Cap (M EUR) 756.23
Shares Outstanding (M) 85.67
30 Day Average Volume 730
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMU

ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. A TAP compound uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.

Daniel M Junius "Dan"President/CEODavid B Johnston "Dave"Exec VP/CFO
John M LambertExec VP/Chief Scientific OfcrCharles Q Morris "Charlie"Exec VP/Chief Development Ofcr
More Company Profile & Key Executives for IMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil